V. Lagente

P. Braquet, V. Lagente, J. Mencia-Huerta, 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Role of endothelin in pulmonary function.

P. Braquet, V. Lagente, E. Boichot, 1992, Pulmonary pharmacology.

Anandamide--a new look on fatty acid ethanolamides.

V. Lagente, E. Boichot, E. Berdyshev, 1996, Journal of lipid mediators and cell signalling.

Effect of selective phosphodiesterase inhibitors on the rat eosinophil chemotactic response in vitro.

V. Lagente, M. Martins, A. Pires, 1997, Memórias do Instituto Oswaldo Cruz.

Models for chronic obstructive pulmonary disease involving matrix metalloproteinases

V. Lagente, E. Boichot, 2006 .

induced inflammation in mice

V. Lagente, J. Planquois, C. Bertrand, 2006 .

Interactions of tachykinin receptor antagonists with lipopolysaccharide‐induced airway inflammation in mice

V. Lagente, E. Boichot, M. Véron, 2004, Clinical and experimental pharmacology & physiology.

Inhaled substance P induces activation of alveolar macrophages and increases airway responses in the guinea-pig

V. Lagente, E. Boichot, N. Frossard, 1993, Neuropeptides.

Neurokinin B‐ and specific tachykinin NK3 receptor agonists‐induced airway hyperresponsiveness in the guinea‐pig

V. Lagente, E. Naline, C. Advenier, 2000, British journal of pharmacology.

Neurokinin Band speci ® c tachykinin NK 3 receptor agonists-induced airway hyperresponsiveness in the guinea-pig 1

V. Lagente, E. Naline, C. Advenier, 2022 .

Involvement of tachykinin NK1 and NK2 receptors in substance P-induced microvascular leakage hypersensitivity and airway hyperresponsiveness in guinea-pigs.

V. Lagente, E. Boichot, C. Advenier, 1996, The European respiratory journal.

OXIDATIVE STRESS IS AN IMPORTANT COMPONENT OF AIRWAY INFLAMMATION IN MICE EXPOSED TO CIGARETTE SMOKE OR LIPOPOLYSACCHARIDE

V. Lagente, J. Planquois, C. Bertrand, 2008, Clinical and experimental pharmacology & physiology.

Role of cyclic AMP in the modulation of IgE production by the beta 2-adrenoceptor agonist, fenoterol.

V. Lagente, O. Coqueret, D. Demarquay, 1996, The European respiratory journal.

Uvaol attenuates pleuritis and eosinophilic inflammation in ovalbumin-induced allergy in mice.

V. Lagente, L. Agra, E. Barreto, 2016, European journal of pharmacology.

Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen‐induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea‐pigs

P. Braquet, V. Lagente, E. Boichot, 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Antigen‐dependent activation of alveolar macrophages from ovalbumin‐sensitized guinea‐pigs: relevance of the route of administration and the amount of antigen provided

V. Lagente, G. Béréziat, B. Vargaftig, 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Enhancement of gelatinase activity during development of subepithelial fibrosis in a murine model of asthma

V. Lagente, E. Boichot, S. Caulet-Maugendre, 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Reduction of matrix metalloproteinase-9 activity by the selective phosphodiesterase 4 inhibitor, RP 73-401 in sensitized mice.

V. Lagente, E. Boichot, C. Belleguic, 2000, European journal of pharmacology.

Contractile activity of big endothelin‐1 on the human isolated bronchus

V. Lagente, E. Naline, C. Advenier, 1992, British journal of pharmacology.

Involvement of a phosphoramidon-sensitive endopeptidase in the processing of big endothelin-1 in the guinea-pig.

P. Braquet, V. Lagente, J. Mencia-Huerta, 1992, European journal of pharmacology.

Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.

P. Braquet, V. Lagente, B. Vargaftig, 1986, European journal of pharmacology.

Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.

P. Braquet, V. Lagente, B. Vargaftig, 1986, Pharmacological research communications.

Pharmacological modulation of the respiratory and haematological changes accompanying active anaphylaxis in the guinea-pig.

B. Vargaftig, V. Lagente, C. Page, 1986, European journal of pharmacology.

Protective effect of a specific platelet-activating factor antagonist, BN 52021, on bupivacaine-induced cardiovascular impairments in rats.

P. Braquet, V. Lagente, Z. Fortes, 1989, Pharmacological research.

Salbutamol potentiates the relaxant effects of selective phosphodiesterase inhibitors on guinea pig isolated trachea

V. Lagente, JM Planquois, Y. Ruffin-Morin, 1996, Fundamental & clinical pharmacology.

Roflumilast n-oxide associated with PGE2 prevents the neutrophil elastase-induced production of chemokines by epithelial cells.

P. Devillier, V. Lagente, E. Boichot, 2016, International immunopharmacology.

MMP-12 induces IL-8/CXCL8 secretion through EGFR and ERK1/2 activation in epithelial cells.

C. Le Quément, V. Lagente, E. Boichot, 2008, American journal of physiology. Lung cellular and molecular physiology.

Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors.

M. Pruniaux, V. Lagente, J. Junien, 1995, American journal of respiratory and critical care medicine.

Inhibition of bleomycin‐induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat

V. Lagente, E. Boichot, S. Caulet-Maugendre, 2001, The Journal of pathology.

Failure of aerosolized endothelin (ET‐1) to induce bronchial hyperreactivity in the guinea pig

P. Braquet, V. Lagente, E. Boichot, 1990, Fundamental & clinical pharmacology.

Morphological and Pharmacological Evidences for the Participation of PAF-Acether in Anaphylactic Shock in the Guinea-Pig

B. Vargaftig, V. Lagente, A. Lellouch‐Tubiana, 1987 .

Inhibition of inflammatory cell recruitment by the tachykinin NK(3)-receptor antagonist, SR 142801, in a murine model of asthma.

V. Lagente, E. Boichot, C. Advenier, 2001, European journal of pharmacology.

Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig.

P. Braquet, V. Lagente, B. Vargaftig, 1986, Pharmacological research communications.

Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig.

V. Lagente, B. Vargaftig, I. Maridonneau-Parini, 1985, Biochemical and biophysical research communications.

A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction.

V. Lagente, B. Vargaftig, J. Lefort, 1986, Prostaglandins.

Effects of interleukin‐10 and modulators of cyclic AMP formation on endotoxin‐induced inflammation in rat lung

V. Lagente, E. Boichot, M. Martins, 1999, Fundamental & clinical pharmacology.

Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients

V. Lagente, E. Boichot, B. Clement, 2003, Critical care medicine.

Interference of the Paf antagonist Ro 19–3704 with Paf and antigen‐induced bronchoconstriction in the guinea‐pig

P. Hadváry, V. Lagente, B. Vargaftig, 1988, British journal of pharmacology.

Pulmonary anti-anaphylactic activity of clenbuterol tested on actively and passively sensitized guinea-pigs.

V. Lagente, B. Vargaftig, J. Lefort, 1985, European journal of pharmacology.

Macrophage elastase (MMP-12): a pro-inflammatory mediator?

S. Nénan, V. Lagente, C. Bertrand, 2005, Memorias do Instituto Oswaldo Cruz.

Failure of a combined anti-histamine and anti-leukotriene treatment to suppress passive anaphylaxis in the guinea-pig.

V. Lagente, B. Vargaftig, J. Randon, 1986, International journal of immunopharmacology.

Endothelin-1 and bronchial hyperresponsiveness in the guinea pig.

P. Braquet, V. Lagente, E. Boichot, 1991, Journal of cardiovascular pharmacology.

Increased Expression of the Low-Affinity Receptor for IgE (FcεRII/CD23) on Rat Alveolar Macrophages

D. Hosford, P. Braquet, V. Lagente, 1992 .

Interference of PAF-acether antagonists with the effects of PAF itself and of anaphylactic shock in in vitro and in vivo guinea-pig bronchopulmonary

V. Lagente, B. Vargaftig, J. Randon, 1985 .

Pharmacological modulation of the effects of N‐formyl‐L‐methionyl‐L‐leucyl‐L‐phenylalanine in guinea‐pigs: involvement of the arachidonic acid cascade

V. Lagente, B. Vargaftig, A. Lellouch‐Tubiana, 1986, British journal of pharmacology.

Bronchopulmonary and pressor activities of endothelin-1 (ET-1), ET-2, ET-3, and big ET-1 in the guinea pig.

P. Braquet, V. Lagente, J. Mencia-Huerta, 1991, Journal of cardiovascular pharmacology.

Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells.

V. Lagente, E. Boichot, N. Allain, 1997, European journal of pharmacology.

Pharmacological modulation of the antigen-induced expression of the low-affinity IgE receptor (Fc epsilon RII/CD23) on rat alveolar macrophages.

P. Braquet, V. Lagente, E. Boichot, 1991, International archives of allergy and applied immunology.

Complete Genome Sequence of Streptococcus pyogenes M/emm44 Strain STAB901, Isolated in a Clonal Outbreak in French Brittany

Pascal Vincent, V. Lagente, S. Kayal, 2014, Genome Announcements.

Impact of JAK/STAT inhibitors on human monocyte‐derived‐macrophages stimulated by cigarette smoke extract and lipopolysaccharide

V. Lagente, E. Barreto, T. Victoni, 2022, Clinical and experimental pharmacology & physiology.

Effects of phosphodiesterase inhibitors and salbutamol on microvascular leakage in guinea-pig trachea.

S. Dahl, V. Lagente, J. Planquois, 1998, European journal of pharmacology.

Selective type IV phosphodiesterase inhibitors prevent IL‐4‐induced IgE production by human peripheral blood mononuclear cells

V. Lagente, E. Boichot, O. Coqueret, 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Anti-inflammatory activities of a new series of selective phosphodiesterase 4 inhibitors derived from 9-benzyladenine.

J. Wallace, J. Bourguignon, V. Lagente, 2000, The Journal of pharmacology and experimental therapeutics.

Anti-Inflammatory Activities of a New Series of Selective Phosphodiesterase 4 Inhibitors Derived from 9-Benzyladenine 1

J. Wallace, J. Bourguignon, V. Lagente, 2000 .

Tachykinin NK3 receptor agonists induced microvascular leakage hypersensitivity in the guinea-pig airways

V. Lagente, E. Naline, A. Ahnaou, 2001 .

Phosphoramidon potentiates the endothelin-1-induced bronchopulmonary response in guinea-pigs

P. Braquet, V. Lagente, E. Boichot, 1991, Neurochemistry International.

Prevention by the tachykinin NK2 receptor antagonist, SR 48968, of antigen‐induced airway hyperresponsiveness in sensitized guinea‐pigs

V. Lagente, E. Boichot, C. Advenier, 1995, British journal of pharmacology.

PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists.

V. Lagente, Z. Fortes, B. Vargaftig, 1988, The Journal of pharmacology and experimental therapeutics.

Bronchopulmonary responses to endothelin‐1 in sensitized and challenged guinea‐pigs: role of cyclooxygenase metabolites and platelet‐activating factor

P. Braquet, V. Lagente, E. Boichot, 1993, Fundamental & clinical pharmacology.

Bronchopulmonary and pressor effects of big-endothelin-1 in the guinea-pig

P. Braquet, V. Lagente, J. Mencia-Huerta, 1991, Neurochemistry International.

Comparison of the effects of intra‐arterial and aerosol administration of endothelin‐1 (ET‐1) in the guinea‐pig isolated lung

P. Braquet, V. Lagente, J. Mencia-Huerta, 1991, British journal of pharmacology.

Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-alpha production by human mononuclear cells.

V. Lagente, E. Boichot, C. Advenier, 2002, International immunopharmacology.

Reduced airway hyperresponsiveness by phosphodiesterase 3 and 4 inhibitors in guinea-pigs.

V. Lagente, J. Planquois, E. Boichot, 1999, Mediators of inflammation.

Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis

J. Tschopp, B. Ryffel, V. Lagente, 2008 .

Suppressive effects of nitric oxide‐releasing prednisolone NCX‐1015 on the allergic pleural eosinophil recruitment in rats

J. Wallace, V. Lagente, M. Martins, 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Effect of Endothelin‐1 on Blood Pressure and Bronchopulmonary System of the Guinea Pig

D. Hosford, P. Braquet, V. Lagente, 1989, Journal of Cardiovascular Pharmacology.

Phosphodiesterase 4 inhibitors and db-cAMP inhibit TNF-α release from human mononuclear cells. Effects of cAMP and cGMP-dependent protein kinase inhibitors

V. Lagente, E. Boichot, A. Hichami, 1996, Mediators of inflammation.

Solid‐phase synthesis and evaluation of libraries of substituted 4,5‐dihydropyridazinones as vasodilator agents

V. Lagente, C. Martin-Chouly, C. Lugnier, 2004, The Journal of pharmacy and pharmacology.

Influence of interleukin-4 and platelet-activating factor on the Fc epsilon RII/CD23 expression on human monocytes.

P. Braquet, V. Lagente, J. Mencia-Huerta, 1990, Journal of lipid mediators.

Regulation of IgE Production by β2‐Adrenoceptor Agonists

P. Braquet, V. Lagente, J. Mencia-Huerta, 1994 .

Influence of inflammasome pathway activation in macrophages on the matrix metalloproteinase expression of human hepatic stellate cells.

V. Lagente, E. Boichot, A. Fautrel, 2019, International immunopharmacology.

Pharmacological modulation of the expression of the low affinity IgE receptor.

P. Braquet, V. Lagente, J. Mencia-Huerta, 1991, Monographs in allergy.

Role of matrix metalloproteinases (MMPs) in cystic fibrosis

V. Lagente, G. Brinchault, C. Belleguic, 2008 .

Adenosine reduces airway excitatory non‐cholinergic (e‐NC) contraction through both A1 and A2 adenosine receptor activation in the guinea pig

V. Lagente, N. Frossard, E. Cano, 1997, Fundamental & clinical pharmacology.

Increased levels of cyclic adenosine monophosphate contribute to the hyporesponsiveness of mast cells in alloxan diabetes.

V. Lagente, M. Martins, C. Lugnier, 2004, International immunopharmacology.

Beta-2-adrenoceptor agonists up-regulate the in vitro Fc epsilon receptor II/CD23 expression on, and release from, the promonocytic cell line U937 and human blood monocytes.

P. Braquet, V. Lagente, J. Mencia-Huerta, 1991, International archives of allergy and applied immunology.

Full-Length Genome Sequence of Type M/emm83 Group A Streptococcus pyogenes Strain STAB1101, Isolated from Clustered Cases in Brittany

V. Lagente, S. Kayal, M. Cariou, 2015, Genome Announcements.

Type 4 phosphodiesterase-dependent pathways: role in inflammatory processes.

V. Lagente, C. Martin-Chouly, C. Jacob, 2002, Therapie.

Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis

V. Lagente, E. Boichot, B. Bailly‐Maitre, 2016, Bioscience reports.

ILr1β production is dependent on the activation of purinergic receptors and NLRP3 pathway in human macrophages

V. Lagente, E. Boichot, P. Loyer, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases

C. Le Quément, V. Lagente, E. Boichot, 2009 .

Uvaol Improves the Functioning of Fibroblasts and Endothelial Cells and Accelerates the Healing of Cutaneous Wounds in Mice

V. Lagente, J. Ferro, E. Barreto, 2020, Molecules.

Arenicola marina extracellular hemoglobin: a new promising blood substitute.

M. Rousselot, V. Lagente, S. Hourdez, 2006, Biotechnology journal.

trans-Cinnamic acid, but not p-coumaric acid or methyl cinnamate, induces fibroblast migration through PKA- and p38-MAPK signalling pathways.

V. Lagente, J. Ferro, E. Barreto, 2021, Journal of tissue viability.

Selective PDE4 inhibitors as potent anti-inflammatory drugs for the treatment of airway diseases.

V. Lagente, E. Boichot, M. Martins, 2005, Memorias do Instituto Oswaldo Cruz.

IL-1 and IL-23 Mediate Early IL-17A Production in Pulmonary Inflammation Leading to Late Fibrosis

B. Ryffel, M. Le Bert, V. Lagente, 2011, PloS one.

The selective MMP‐12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke

C. Le Quément, V. Lagente, E. Boichot, 2008, British journal of pharmacology.

IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.

S. Akira, B. Ryffel, V. Lagente, 2007, The Journal of clinical investigation.

Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury.

V. Lagente, E. Boichot, M. Corbel, 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough.

V. Lagente, E. Boichot, C. Advenier, 1997, The European respiratory journal.

Involvement of purinergic receptors and NOD‐like receptor‐family protein 3‐inflammasome pathway in the adenosine triphosphate‐induced cytokine release from macrophages

V. Lagente, E. Boichot, A. Fautrel, 2014, Clinical and experimental pharmacology & physiology.

Purinergic receptors: new targets for the treatment of gout and fibrosis

V. Lagente, E. Boichot, T. Gicquel, 2017, Fundamental & clinical pharmacology.

Role of matrix metalloproteinases in the inflammatory process of respiratory diseases.

V. Lagente, E. Boichot, 2010, Journal of molecular and cellular cardiology.

The selective phosphodiesterase 4 inhibitor RP 73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-beta release during acute lung injury in mice: the role of the balance between Tumor necrosis factor-alpha and interleukin-10.

V. Lagente, E. Boichot, M. Martins, 2002, The Journal of pharmacology and experimental therapeutics.

Propolis reversed cigarette smoke-induced emphysema through macrophage alternative activation independent of Nrf2.

V. Lagente, L. C. Pôrto, S. Valença, 2017, Bioorganic & medicinal chemistry.

IL-1R1/MyD88 Signaling Is Critical for Elastase-Induced Lung Inflammation and Emphysema1

B. Ryffel, V. Lagente, V. Vasseur, 2009, The Journal of Immunology.

Emphysema Elastase-Induced Lung Inflammation and IL-1 R 1 / MyD 88 Signaling Is Critical for

B. Ryffel, V. Lagente, V. Vasseur, 2009 .

Time Course of the Phenotype of Blood and Bone Marrow Monocytes and Macrophages in the Lung after Cigarette Smoke Exposure In Vivo

V. Lagente, A. Monte-Alto-Costa, L. Porto, 2017, International journal of molecular sciences.

Oxidative stress causes hypertension and activation of nuclear factor-κB after high-fructose and salt treatments

V. Lagente, Maísa Silva, A. Alzamora, 2017, Scientific Reports.

Role of matrix metalloproteinases in the development of airway inflammation and remodeling.

C. Le Quément, V. Lagente, E. Boichot, 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease

V. Lagente, J. Planquois, C. Bertrand, 2004, Inflammation Research.

Inhibitory effect of cyclosporin A on eosinophil infiltration in the guinea-pig lung induced by antigen, platelet-activating factor and leukotriene B4.

P. Braquet, V. Lagente, E. Boichot, 1994, The European respiratory journal.

Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.

V. Lagente, M. Martins, B. Diaz, 1996, European journal of pharmacology.

Matrix Metalloproteinase Inhibitors as New Anti-inflammatory Drugs

V. Lagente, E. Boichot, T. Victoni, 2011 .

Comparative effects of betamethasone, cyclosporin and nedocromil sodium in acute pulmonary inflammation and metalloproteinase activities in bronchoalveolar lavage fluid from mice exposed to lipopolysaccharide.

V. Lagente, E. Boichot, B. Clement, 1999, Pulmonary pharmacology & therapeutics.

Anti-inflammatory properties of MMP inhibitors in experimental models of chronic obstructive pulmonary disease and lung inflammation

V. Lagente, E. Boichot, J. Gillon, 2008 .

Roflumilast N-Oxide Prevents Cytokine Secretion Induced by Cigarette Smoke Combined with LPS through JAK/STAT and ERK1/2 Inhibition in Airway Epithelial Cells

V. Lagente, E. Boichot, L. C. Pôrto, 2014, PloS one.

Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis

V. Lagente, E. Boichot, C. Belleguic, 2004, Cell Biology and Toxicology.

The release of pro‐inflammatory cytokines is mediated via mitogen‐activated protein kinases rather than by the inflammasome signalling pathway in keratinocytes

V. Lagente, C. Coulouarn, T. Gicquel, 2017, Clinical and experimental pharmacology & physiology.

Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.

J. Wallace, B. Vargaftig, V. Lagente, 1987, Gastroenterology.

Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors.

M. Pruniaux, V. Lagente, C. Bertrand, 2004, Life sciences.

Lack of involvement of type 7 phosphodiesterase in an experimental model of asthma

V. Lagente, C. Bertrand, X. Palazzi, 2011, European Respiratory Journal.

Selective phosphodiesterase inhibitors modulate the activity of alveolar macrophages from sensitized guinea-pigs.

B. Bertin, B. Martin, V. Lagente, 1998, The European respiratory journal.

Analysis of the inflammatory response induced by rhMMP-12 catalytic domain instilled in mouse airways.

P. Berna, S. Hitier, S. Nénan, 2005, International immunopharmacology.

Interleukin-8 induction by the environmental contaminant benzo(a)pyrene is aryl hydrocarbon receptor-dependent and leads to lung inflammation.

O. Fardel, L. Sparfel, D. Gilot, 2008, Toxicology letters.

Ethanol upregulates the P2X7 purinergic receptor in human macrophages

V. Lagente, P. Loyer, T. Gicquel, 2018, Fundamental & clinical pharmacology.

Macrophage metalloelastase (MMP-12) deficiency does not alter bleomycin-induced pulmonary fibrosis in mice

S. Nénan, V. Lagente, J. Planquois, 2006, Journal of Inflammation.

Effects of isozyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea-pig lung.

V. Lagente, J. Junien, J L Junien, 1994, European journal of pharmacology.

Specific blockade of morphine- and cocaine-induced reinforcing effects in conditioned place preference by nitrous oxide in mice

V. Lagente, F. Noble, N. Benturquia, 2007, Neuroscience.

Corticosteroids in Severe Sepsis

D. Annane, V. Lagente, É. Bellissant, 2001 .

A tachykinin NK3 receptor antagonist, SR 142801 (osanetant), prevents substance P-induced bronchial hyperreactivity in guinea-pigs.

V. Lagente, C. Advenier, X. Emonds-alt, 1997, Pulmonary pharmacology & therapeutics.

Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases.

C. Le Quément, V. Lagente, E. Boichot, 2009, Expert opinion on therapeutic targets.

Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis

V. Lagente, Waleska Dornas, 2019, Pharmacological research.

Endotoxin regulates matrix genes increasing reactive oxygen species generation by intercellular communication between palmitate‐treated hepatocyte and stellate cell

V. Lagente, D. Glaise, S. Dutertre, 2018, Journal of cellular physiology.

Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice

V. Lagente, J. Planquois, C. Bertrand, 2006, European Respiratory Journal.

Effects of depletion of neutrophils or macrophages on the inflammatory response induced by metalloelastase (MMP-12) in mice airways.

P. Berna, S. Hitier, S. Nénan, 2008, European journal of pharmacology.

DMSO-treated HL60 cells: a model of neutrophil-like cells mainly expressing PDE4B subtype.

Janet M. Allen, V. Lagente, C. Bertrand, 2002, International immunopharmacology.

Role of PDE4 in superoxide anion generation through p44/42MAPK regulation: a cAMP and a PKA‐independent mechanism

Janet M. Allen, V. Lagente, C. Bertrand, 2004, British journal of pharmacology.

Long‐lasting inhibitory activity of the hetrazepinic BN 50730 on exudation and cellular alterations evoked by PAF and LPS

P. Braquet, V. Lagente, M. Martins, 1994, British journal of pharmacology.

Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice.

V. Lagente, E. Boichot, Y. Mallédant, 2001, European journal of pharmacology.

Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activity

V. Lagente, E. Boichot, B. Clement, 2001, Inflammation Research.

Role of matrix metalloproteinases in the development of airway inflammation and remodeling.

S. Nénan, V. Lagente, E. Boichot, 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Effects of phosphodiesterase inhibitors and salbutamol on microvascular leakage in guinea-pig trachea.

S. Dahl, V. Lagente, J. Planquois, 1998, European Journal of Pharmacology.

A Novel Protein Epitope Mimetic (PEM) Neutrophil Elastase (NE) Inhibitor, POL6014, Inhibits Human NE-Induced Acute Lung Injury in Mice.

V. Lagente, I. Morel, É. Chevalier, 2009, ATS 2009.

Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis.

J. Tschopp, B. Ryffel, V. Lagente, 2009, American journal of respiratory and critical care medicine.

ILr1β production is dependent on the activation of purinergic receptors and NLRP3 pathway in human macrophages

V. Lagente, E. Boichot, P. Loyer, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Effects of SR 140333 and SR 48968 on antigen and substance P‐induced activation of guinea‐pig alveolar macrophages

V. Lagente, E. Boichot, N. Germain, 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Interactions between cAMP- and cGMP-dependent protein kinase inhibitors and phosphodiesterase IV inhibitors on arachidonate release from human monocytes.

V. Lagente, E. Boichot, A. Hichami, 1996, Life sciences.

Modulation of IgE Production in the Mouse by β2-Adrenoceptor Agonist

P. Braquet, V. Lagente, J. Mencia-Huerta, 1994 .